A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience

Journal of Human Reproductive Sciences

Volumn 5, Issue 2, 2012, Pages 181-186

  Kaur, Harpreet ^a   Krishna, Deepika ^a   Krishnan, Sandhya ^a   Rao, Kamini Arvind ^a   Shetty, Nivedita ^a   Srinivas, M ^a  

^a Bangalore Assisted Conception Centre   (India)

Author keywords

COS; IVF outcome; PCOS

Indexed keywords

ESTRADIOL; GANIRELIX; LEUPRORELIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BIRTH RATE; CELL COUNT; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INDIA; LIVE BIRTH; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY FOLLICLE CELL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREGNANCY RATE; PROSPECTIVE STUDY;

EID: 84866723046     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.101019     Document Type: Article

References (19)

1. Lainas TG, Ioannis S, Zorzovillis IZ, Petsas GK, Lainas GT, Alexopoulou E, et al. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: A prospective randomized controlled trial (RCT). Hum Reprod 2010;25:683-9.
2. Orvieto R, Meltcer S, Homburg R, Nahum R, Rabinson J, Ashkenazi J. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2009;91(4 Suppl):1466-8.
3. Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
4. Thessaloniki ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008;89:505-22.
5. Ragni G, Vegetti W, Riccaboni A, Engl B, Brigante C, Crosignani PG. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Hum Reprod 2005;20:2421-5.
6. Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRHantagonists in ovarian stimulation for IVF in patients with poor response to gonadotropins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: A meta-analysis. Reprod Biomed Online 2006;13:628-38.
7. Tarlatzis BC, Kolibianakis EM. GnRH agonists vs antagonists. Best Pract Res Clin Obstet Gynaecol 2007;21:57-65.
8. Lin YC, Chang SY, Lan KC, Huang HW, Chang CY, Tsai MY, et al. Human oocyte maturity in vivo determines the outcome of the blastocyst development in vitro. J Assist Reprod Genet 2003;20:506-12.
9. Veek L. An Atlas of human gametes and conceptuses. London: Parthenon; 1999. p. 215.
10. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989;44:430-40.
11. Navot D, Bergh P, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61.
12. Ovarian hyperstimulation syndrome. Educational Bulletin, The Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2008;90(Suppl 3):S188-93.
13. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006;12:651-71.
14. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2006;3:CD001750.
15. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, et al. Gonadotrophin releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011;(5):CD001750.
16. Ashrafi M, Moini A, Mohammadzadeh A Ezabadi Z, Zafarani F, Baghestani AR, et al. A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian J Reprod Med 2005;3:14-8.
17. Felberbaum R. Gonadotropin-releasing hormone antagonists: Will they replace agonists? Reprod Biomed Online 2002;6:43-53.
18. Reh A, Lewis Krey MD, Noyes N. Are gonadotropin-releasing hormone agonists loosing popularity? Current trends at a large fertility centre. Fertil Steril 2010;93:101-8.
19. Fauser BC, Nargund G, Andersen AN, Norman R, Tarlatzis B, Boivin J, et al. Mild ovarian stimulation for IVF: 10 years later. Hum Reprod 2010;25:2678-84.